3-(Aminomethyl)piperazine-2,5-dione as a novel NMDA glycine site inhibitor from the chemical universe database GDB

Add time:09/03/2019    Source:sciencedirect.com

Docking of randomly selected compounds from the chemical universe database GDB-11, which contains all organic molecules up to 11 atoms of C, N, O, F possible under consideration of simple chemical stability and synthetic feasibility rules, into the NMDA receptor glycine site (1pb7.pdb) lead to the identification of 3-(aminomethyl)piperazine-2,5-dione 3 and its close analog 5-(aminomethyl)piperazine-2,3-dione 4 as possible new ligands for this drug target, which is implicated in synaptic plasticity, neuronal development, learning and memory. Synthesis of these compounds in 4 and 6 steps, respectively, and testing by radioligand displacement assays and electrophysiological measurements in Xenopus oocytes show that while 4 is inactive, 3 is indeed an inhibitor of glycine, with an estimated KD of 50 μM.

We also recommend Trading Suppliers and Manufacturers of 1-Boc-3-(aMinoMethyl)-3-hydroxypyrrolidine (cas 114214-73-2). Pls Click Website Link as below: cas 114214-73-2 suppliers

Prev:A novel and efficient synthesis of 3-aminomethyl-N-tosyl-indazoles
Next:Syntheses and absolute configurations of the marine sponge purines (+)-agelasimine-A and (+)-agelasimine-B)